Clinical Trials Directory

Trials / Conditions / Multiple Myeloma, Newly Diagnosed

Multiple Myeloma, Newly Diagnosed

8 registered clinical trials studyying Multiple Myeloma, Newly Diagnosed — 7 currently recruiting.

StatusTrialSponsorPhase
RecruitingMRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma
NCT07106736
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2
RecruitingASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multipl
NCT07106710
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2
RecruitingFrontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guide
NCT06974786
SCRI Development Innovations, LLCPhase 2
RecruitingElranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Indu
NCT06918002
Intergroupe Francophone du MyelomePhase 3
Not Yet RecruitingComparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT
NCT06963866
Xuzhou Medical UniversityPhase 2
RecruitingLow Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients
NCT06758375
Hospital Universitario Dr. Jose E. GonzalezPhase 2
RecruitingKPD Consolidation After ASCT in NDMM Patients
NCT06879379
Peking University People's HospitalPhase 2 / Phase 3
UnknownClinical Implication of Bone Marrow Perfusion Patterns Imaged by Dynamic MRI in Multiple Myeloma
NCT00166855
National Taiwan University HospitalN/A